MedPath

A comparison between the side effects of two methods of Contraceptio

Phase 2
Conditions
Contraception.
General counselling and advice on contraception
Registration Number
IRCT138903242624N6
Lead Sponsor
Iran University of Medical Sciences, Deputy of Research and Technology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
1000
Inclusion Criteria

non pregnant and married women who are 18-35 years old and are serious for not to be pregnant during the next year and their BMI is in the normal range (19-25). Exclusion criteria: history of breast cancer, endometrial cancer, abnormal uterine bleeding , being smoker, active or chronic liver disease , obstructive jaundice, liver adenoma or carcinoma, liver cirrhosis, thromboembolic disorders, heart disease, stroke, diabetes, hypertension, recurrent headache or dizziness, history of depression or anxiety, breast feeding, dislipidemia, any systemic disorder or any drug use for systemic disorders, AUB , Oligomenorhea.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Adverse effects. Timepoint: 1-3-6-12 months. Method of measurement: questionnaire.
Secondary Outcome Measures
NameTimeMethod
The frequency of discontinuation of contraception. Timepoint: 1-3-6-12 months. Method of measurement: Questionnaire.
© Copyright 2025. All Rights Reserved by MedPath